Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piet Dirix

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
European Urology Oncology|April 3, 2024
Multi-institutional Analysis of Metastasis-directed Therapy with or Without Androgen Deprivation Therapy in Oligometastatic Castration-sensitive Prostate CancerMatthew P Deek, Philip Sutera, Yuezhou Jing, et al.
The Lancet. Oncology|May 8, 2025
Salvage metastasis-directed therapy versus elective nodal radiotherapy for oligorecurrent nodal prostate cancer metastases (PEACE V-STORM): a phase 2, open-label, randomised controlled trialPiet Ost, Shankar Siva, Sigmund Brabrand, et al.
European Urology Focus|January 2, 2021
The Multicenter, Randomized, Phase 2 PEACE V-STORM Trial: Defining the Best Salvage Treatment for Oligorecurrent Nodal Prostate Cancer MetastasesThomas Zilli, Piet Dirix, Reino Heikkilä, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 27, 2022
Oligorecurrent nodal prostate cancer: Radiotherapy quality assurance of the randomized PEACE V-STORM phase II trialVérane Achard, Maud Jaccard, Frederik Vanhoutte, et al.
European Urology Oncology|October 11, 2023
PEACE V-Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 TrialPiet Ost, Shankar Siva, Sigmund Brabrand, et al.
European Urology|July 24, 2019
Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal RadiotherapyElise De Bleser, Barbara Alicja Jereczek-Fossa, David Pasquier, et al.
British Journal of Cancer|June 1, 2022
Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insightsEmily Latacz, Diederik Höppener, Ali Bohlok, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
European Urology Oncology|April 3, 2024
Multi-institutional Analysis of Metastasis-directed Therapy with or Without Androgen Deprivation Therapy in Oligometastatic Castration-sensitive Prostate CancerMatthew P Deek, Philip Sutera, Yuezhou Jing, et al.
The Lancet. Oncology|May 8, 2025
Salvage metastasis-directed therapy versus elective nodal radiotherapy for oligorecurrent nodal prostate cancer metastases (PEACE V-STORM): a phase 2, open-label, randomised controlled trialPiet Ost, Shankar Siva, Sigmund Brabrand, et al.
European Urology Focus|January 2, 2021
The Multicenter, Randomized, Phase 2 PEACE V-STORM Trial: Defining the Best Salvage Treatment for Oligorecurrent Nodal Prostate Cancer MetastasesThomas Zilli, Piet Dirix, Reino Heikkilä, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 27, 2022
Oligorecurrent nodal prostate cancer: Radiotherapy quality assurance of the randomized PEACE V-STORM phase II trialVérane Achard, Maud Jaccard, Frederik Vanhoutte, et al.
European Urology Oncology|October 11, 2023
PEACE V-Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 TrialPiet Ost, Shankar Siva, Sigmund Brabrand, et al.
European Urology|July 24, 2019
Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal RadiotherapyElise De Bleser, Barbara Alicja Jereczek-Fossa, David Pasquier, et al.
British Journal of Cancer|June 1, 2022
Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insightsEmily Latacz, Diederik Höppener, Ali Bohlok, et al.
Pageof 9